CCM
ABBV icon

Crew Capital Management’s AbbVie ABBV Stock Holding History

Crew Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Buy
8,551
+332
+4% +$71.4K 1.18% 26
2026
Q1 		$1.79M Sell
8,219
-151
-2% -$33.5K 1.19% 24
2025
Q4 		$1.91M Buy
8,370
+424
+5% +$96.6K 1.2% 21
2025
Q3 		$1.84M Sell
7,946
-14
-0.2% -$2.85K 1.23% 19
2025
Q2 		$1.48M Buy
7,960
+4,424
+125% +$822K 1.06% 23
2025
Q1 		$741K Buy
3,536
+49
+1% +$9.53K 0.6% 63
2024
Q4 		$620K Buy
3,487
+1
+0% +$184 0.51% 69
2024
Q3 		$688K Sell
3,486
-101
-3% -$18.9K 0.55% 67
2024
Q2 		$615K Buy
3,587
+1
+0% +$166 0.49% 67
2024
Q1 		$653K Buy
3,586
+1,306
+57% +$225K 0.53% 65
2023
Q4 		$353K Sell
2,280
-235
-9% -$34.3K 0.36% 55
2023
Q3 		$375K Sell
2,515
-158
-6% -$23.2K 0.4% 50
2023
Q2 		$360K Sell
2,673
-36
-1% -$5.28K 0.41% 56
2023
Q1 		$432K Sell
2,709
-40
-1% -$6.12K 0.62% 36
2022
Q4 		$444K Sell
2,749
-126
-4% -$19.3K 0.64% 36
2022
Q3 		$386K Buy
2,875
+140
+5% +$20.1K 0.53% 49
2022
Q2 		$419K Hold
2,735
– – 0.53% 48
2022
Q1 		$443K Sell
2,735
-33
-1% -$4.79K 0.43% 55
2021
Q4 		$375K Hold
2,768
– – 0.32% 68
2021
Q3 		$299K Hold
2,768
– – 0.28% 77
2021
Q2 		$312K Hold
2,768
– – 0.29% 74
2021
Q1 		$300K Buy
+2,768
New +$296K 0.3% 76

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Crew Capital Management's ABBV Position: Q2 2026 in Review

Crew Capital Management increased its AbbVie (ABBV) stake by 4% in Q2 2026, buying an estimated $71.4K and bringing the position to 8,551 shares worth $2.15M. The position accounts for 1.18% of the portfolio, ranked #26.

Crew Capital Management first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Crew Capital Management held 8,551 shares of AbbVie worth $2.15M as of Q2 2026.
  • Crew Capital Management bought 332 AbbVie shares in Q2 2026, an estimated $71.4K.
  • AbbVie made up 1.18% of Crew Capital Management's portfolio in Q2 2026, its #26 holding.
  • Crew Capital Management first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Crew Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.